Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 49.9% based on the past 3 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $65.96. The Score for PCVX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • PCVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 49.9% based on the past 3 years of stock performance.

Vaxcyte Stock Rating

Buy
77
Vaxcyte (PCVX) is a Buy

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCVX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
82.04
52-Week Low:
44.20

Prediction Charts

Market Cap:
7.15B
Price in USD:
65.96
Volume:
618.8K
Beta:
0.96

Technical Analysis

SMA50:
67.00
SMA100:
66.42
SMA200:
58.00
52-Wk Change:
33.28%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 65.96 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 62.17 62.29 62.86 61.84
Apr-17 62.65 62.43 63.44 61.78
Apr-18 62.15 60.62 62.21 60.58
Apr-19 60.46 60.88 61.92 59.39
Apr-22 61.47 61.60 63.22 60.91
Apr-23 61.79 60.88 62.56 60.83
Apr-24 61.05 60.30 61.98 59.97
Apr-25 59.59 60.06 60.09 58.10
Apr-26 60.32 60.72 60.95 59.41
Apr-29 61.07 61.03 62.29 60.72
Apr-30 60.61 60.54 61.20 58.84
May-1 60.76 63.71 64.24 60.21
May-2 63.83 64.55 65.00 63.11
May-3 66.48 65.96 67.08 65.46

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.85 per share, and a decrease next year of $0.05 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.